EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The last update, which, I believe, is another huge one, would be that the goal of this company is to expand the use of ...

Phase one of the transaction is expected to be completed by the end of January next year ... Edmond Scanlon, the CEO of Kerry ...

Last month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward ...

NRBO READ THE FULL NRBO RESEARCH REPORT Business Update Topline Results from Phase 2a Trial of DA-1241 in MASH Expected in ...

A modern, flexible office space at One Central, The Offices 2, Level 2, has been leased on a long-term basis to a single ...

Announcing the partnership today, Corrib confirmed that as part of the first phase of the agreement, it plans to open ten ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Power Metals Corp ("Power Metals" or the "Company") (TSXV: PWM) (FRANKFURT: OAA1) (OTCQB: PWRMF) is pleased to confirm Black ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

The company completed its patient enrollment for its Phase 2b IMPACT trials targeting MASH ... I'd find that concerning if ...

The second phase of Courier Square by Greystar and Evening Post Industries includes a mixed-use retail and apartment ...